Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2020 17:20 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020

CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...
October 08, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA

RP2 Panel at a Glance GenMark’s ePlex® Respiratory Pathogen Panel 2 (RP2 Panel) has received Emergency Use Authorization from the FDA.The RP2 Panel provides results in less than two hours for more...
October 08, 2020 16:03 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020

CARLSBAD, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
September 15, 2020 09:04 ET | Source: GenMark Diagnostics, Inc.

Le Panel de pathogènes respiratoires 2 (RP2) ePlex de GenMark Diagnostics obtient le marquage CE

Le test syndromique moléculaire pour la COVID-19, la grippe et d'autres pathogènes respiratoires courants aide les professionnels de santé à se préparer à la saison de la grippe Le Panel RP2 en un...
September 14, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark

Molecular syndromic test for COVID-19, influenza and other common respiratory pathogenshelps health care professionals prepare for flu season RP2 Panel at a Glance GenMark’s ePlex® Respiratory...
August 17, 2020 08:00 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test

CARLSBAD, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that it has...
August 04, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports Second Quarter 2020 Results

CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
July 29, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
July 21, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020

CARLSBAD, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close...
July 07, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020

CARLSBAD, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...